Erasca, Inc. - ERAS

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A Paradigm BioCapital Advisors LP 3.3% 10,392,702 View
May 15, 2026 SCHEDULE 13G/A Paradigm BioCapital Advisors GP LLC 3.3% 10,392,702 View
May 15, 2026 SCHEDULE 13G/A Senai Asefaw, M.D. 3.3% 10,392,702 View
May 15, 2026 SCHEDULE 13G/A Paradigm BioCapital International Fund Ltd. 2.9% 9,157,687 View
May 15, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners III, L.P. 5.3% 16,382,812 View
May 15, 2026 SCHEDULE 13G/A VHCP Co-Investment Holdings III, LLC 5.3% 16,382,812 View
May 15, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners EG, L.P. 5.3% 16,382,812 View
May 15, 2026 SCHEDULE 13G/A VHCP Management III, LLC 5.3% 16,382,812 View
May 15, 2026 SCHEDULE 13G/A VHCP Management EG, LLC 5.3% 16,382,812 View
May 15, 2026 SCHEDULE 13G/A Nimish Shah 5.3% 16,382,812 View
May 15, 2026 SCHEDULE 13G/A Bong Y. Koh 5.3% 16,382,812 View
May 15, 2026 SCHEDULE 13G/A T. Rowe Price Investment Management, Inc. 6.8% 21,224,264 View
May 15, 2026 SCHEDULE 13G RTW Investments, LP 5.2% 16,157,175 View
May 15, 2026 SCHEDULE 13G Roderick Wong 5.2% 16,157,175 View
May 12, 2026 SCHEDULE 13G/A Suvretta Capital Management, LLC 1.1% 3,434,967 View
May 12, 2026 SCHEDULE 13G/A Averill Master Fund, Ltd. 0.9% 2,945,497 View
May 12, 2026 SCHEDULE 13G/A Aaron Cowen 1.1% 3,434,967 View
Feb 17, 2026 SCHEDULE 13G/A T. Rowe Price Investment Management, Inc. 5.7% 16,111,414 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.